X4 Pharmaceuticals Inc (NASDAQ: XFOR) on Friday, soared 23.27% from the previous trading day, before settling in for the closing price of $3.18. Within the past 52 weeks, XFOR’s price has moved between $1.35 and $26.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 47.41% over the last five years. The company achieved an average annual earnings per share of 58.89%. With a float of $6.37 million, this company’s outstanding shares have now reached $7.96 million.
X4 Pharmaceuticals Inc (XFOR) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of X4 Pharmaceuticals Inc is 71.62%, while institutional ownership is 19.65%. The most recent insider transaction that took place on May 16 ’25, was worth 2,561. In this transaction Chief Commercial Officer of this company bought 1,032 shares at a rate of $2.48, taking the stock ownership to the 25,337 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -5.4 earnings per share (EPS) for the period falling under the consensus outlook (set at -5.16) by -0.24. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.7 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.89% per share during the next fiscal year.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
X4 Pharmaceuticals Inc (XFOR) is currently performing well based on its current performance indicators. A quick ratio of 3.05 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.69.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -14.80, a number that is poised to hit -3.25 in the next quarter and is forecasted to reach -1.33 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Analysing the last 5-days average volume posted by the [X4 Pharmaceuticals Inc, XFOR], we can find that recorded value of 3.77 million was better than the volume posted last year of 1.66 million. As of the previous 9 days, the stock’s Stochastic %D was 85.26%.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 42.20%, which indicates a significant decrease from 99.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.50 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.08, while its 200-day Moving Average is $8.95. Now, the first resistance to watch is $4.19. This is followed by the second major resistance level at $4.47. The third major resistance level sits at $5.00. If the price goes on to break the first support level at $3.38, it is likely to go to the next support level at $2.85. Now, if the price goes above the second support level, the third support stands at $2.57.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
Market capitalization of the company is 88.00 million based on 11,408K outstanding shares. Right now, sales total 2,560 K and income totals -37,450 K. The company made 1,970 K in profit during its latest quarter, and -25,740 K in sales during its previous quarter.
